The prevalence of men with National Institutes of Health category IV prostatitis and association with serum prostate specific antigen.

These data suggest that NIH category IV prostatitis is fairly prevalent (32.2%) among men in the general population who present for prostate cancer screening and appears to contribute to increased serum PSA levels in some men.